Specialty Pharmacy

Mortality from opioids may be higher than it appears.

National HIV Testing Day, designated by the CDC, aims to encourage individuals to know their status.

New data demonstrate that evolocumab (Repatha) significantly reduced low-density lipoprotein cholesterol and non-high density lipoprotein cholesterol in patients with type 2 diabetes plus hypercholesterolemia or mixed dyslipidemia.

A novel epigenetic drug can be combined with an existing therapy, venetoclax, to more effectively kill high-risk neuroblastoma cells.

Top news of the day from across the health care landscape

Elotuzumab with pomalidomide and low-dose dexamethasone met its primary endpoint in showing a statistically significant, clinically meaningful improvement in progression-free survival in patients with relapsed/refractory multiple myeloma.

Officials with the FDA have approved plazomicin (Zemdri, Achaogen) for the treatment of adults with complicated urinary tract infections (cUTIs), caused by certain Enterobacteriaceae, in patients with limited or no alternative treatment.

Epidiolex is the first FDA-approved drug that contains an active ingredient derived from marijuana and is the first approved treatment for patients with Dravet syndrome.

Current definitions attempting to summarize specialty pharmacy fall short.

The findings highlight the role of Epstein-Barr virus (EBV) infection in multiple sclerosis pathogenesis and support therapies targeting EBV-infected immune cells.

Top news of the day from across the health care landscape

Many individuals at high risk of getting HIV—including those who inject drugs, gay and bisexual men, and partners of people with HIV—are not screened annually and experience delays in diagnosis.

Matthew Hughes, director of Business Development for the Accreditation Commission for Health Care (ACHC), discusses developments for ACHC in the pharmacy accreditation space.

A look at last week's top stories in the world of pharmacy.

Top news of the week from Specialty Pharmacy Times.

New data show an association between potentially inappropriate prescribing practices and higher risk of all-cause mortality, and both fatal and non-fatal overdose.

Top news of the day from across the health care landscape

Nivolumab plus low-dose ipilimumab demonstrated positive initial results in part 1 of a phase 3 study.

Following results of decreased survival associated with the use of these medications as a single therapy, the FDA is restricting use in some patients with urothelial cancer.

Adults who survive an opioid overdose are 24 times more likely to die during the year after the incident from a variety of mental health and medical conditions.

Researchers identified an epigenetic mechanism connected to a known genetic risk factor for multiple sclerosis.

Top news of the day from across the health care landscape

Pharmacist-led refill authorizations are a practical solution to the nation’s health care crisis, helping to improve quality while reducing costs as well as saving physicians’ time.

Tonsillectomy was associated with an almost tripled relative risk for upper respiratory diseases, including asthma, influenza, pneumonia, and chronic obstructive pulmonary disorder.

Top news of the day from across the health care landscape

Phase 3 data show that ocrelizumab (Ocrevus) may delay the progression of disability, such as the need for a wheelchair, in patients with primary progressive multiple sclerosis (PPMS).

The label update includes new evidence that the treatment significantly impedes the progression of joint structural damage at 24 weeks compared to placebo for patients with active psoriatic arthritis.

Quizartinib has prolonged survival in patients with a rare and deadly form of acute myeloid leukemia.

Researchers investigated whether high body mass index is a risk factor not only for a greater risk of multiple sclerosis, but also for advancing to the secondary progressive stage of the disease.

A form of artificial intelligence known as a deep learning convolutional neural network outperformed dermatologists in diagnosing malignant melanomas.